Научная электронная библиотека
Монографии, изданные в издательстве Российской Академии Естествознания
ПАРАТГОРМОН-РОДСТВЕННЫЙ ПРОТЕИН. 2-е издание переработанное и дополненное
Курзанов А. Н., Ледванов М. Ю., Быков И. М., Медведев В. Л., Стрыгина Е. А., Бизенкова М. Н., Заболотских Н. В., Ковалев Д. В., Стукова Н. Ю.,
Литература к главе 1
1. Abbink W., Flik G. Parathyroid hormone-related protein in teleost fish. Gen Comp Endocrinol. 2007; 152 (2-3): 243-251.
2. Abou-Samra A.B., Juppner H., Force T. et al. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Proc. Natl. Acad. Sci. USA. 1992; 89: 2732–2736.
3. Abou-Samra A.B., Juppner H., Westerberg D. et al. Parathyroid hormone causes translocation of protein kinase-C from cytosol to membranes in rat osteosarcoma cells. Endocrinology. 1989; 124 (3): 1107–1113.
4. Albright F. Case records of the Massachusetts General Hospital (case 27461) N Engl J Med. 1941; 225 (20): 789-791.
5. Alexander S.P., Benson H.E., Faccenda E., Pawson A.J., Sharman J.L., Spedding M., Peters J.A., Harmar A.J., and CGTP Collaborators The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br. J Pharmacol. 2013; 170: 1459–1481.
6. Allinson E.T., Drucker D.J. Parathyroid hormone-like peptide shares features with members of the early response gene family: rapid induction by serum, growth factors, and cycloheximide. Cancer Res. 1992; 52: 3103–3109.
7. Alokai M.S. Molecular signalling of PTHrP in tumor. In Novel Aspects of PTHrP Physiopathology; Luparello, C. Ed; Nova Science Publishers: New York, NY, USA, 2007; pp. 191–233.
8. Amizuka N., Lee H.S., Kwan M.Y. et al. Cell-specific expression of the parathyroid hormone (PTH)/PTH-related peptide receptor gene in kidney from kidney-specific and ubiquitous promoters // Endocrinology. 1997; 138 (1): 469-481.
9. Ardura J.A., Wang B., Watkins S.C., Vilardaga J.P., and Friedman P/A. Dynamic Na+-H+ exchanger regulatory factor-1 association and dissociation regulate parathyroid hormone receptor trafficking at membrane microdomains. J Biol Chem.2011; 286: 35020–35029.
10. Bago A.G., Dimitrov E., Saunders R., Seress L., Palkovits M., Usdin T.B., Dobolyi A. Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience. 2009; 162: 128–147.
11. Bago A.G., Palkovits M., Usdin T.B., Seress L., Dobolyi A. Evidence for the expression of parathyroid hormone 2 receptor in the human brainstem. Ideggyogy Sz. 2008; 61: 123–126.
12. Barden J.A., Cuthbertson R.M. (1993) Stabilized NMR structure of human parathyroid hormone (1–34). Eur J Biochem. 1993; 215 (2): 315-321.
13. Behar V., Pines M., Nakamoto C., Greenberg Z., Bisello A., Stueckle S.M., Bessalle R., Usdin T.B., Chorev M., Rosenblatt M., Suva L.J. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor. Endocrinology. 1996; 137: 2748–2757.
14. Berg K.A., Clarke W.P. Making sense of pharmacology: inverse agonismand functional selectivity. Int J Neuropsychopharmacol. 2018; 21: 962–77.
15. Bergwitz C., Gardella T.J., Flannery M.R., Potts J.T., Jr., Kronenberg, H.M., Goldring S.R., Juppner H. Full activation of chimeric receptors by hybrids between parathyroid hormone and calcitonin. Evidence for a common pattern of ligand-receptor interaction. The Journal of biological chemistry. 1996; 271: 26469-26472.
16. Betel D., Koppal A., Agius P., Sander C., Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 2010; 11: R90.
17. Bhattacharya P., Yan Y.L, Postlethwait J., Rubin D.A. Evolution of the vertebrate pth2 (tip39) gene family and the regulation of PTH type 2 receptor (pth2r) and its endogenous ligand pth2 by hedgehog signaling in zebrafish development. J Endocrinol. 2011; 211: 187–200. doi: 10.1530/JOE-10-0439.
18. Bisello A., Manen D., Pierroz D.D., Usdin T.B., Rizzoli R., Ferrari S.L. Agonist-specific regulation of parathyroid hormone (PTH) receptor type 2 activity: structural and functional analysis of PTH- and tuberoinfundibular peptide (TIP) 39-stimulated desensitization and internalization. Mol Endocrinol. 2004 Jun; 18 (6): 1486-98.
19. Blind E., Raue F., Knappe V., Schroth J., Ziegler R. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1–34 and PTH 1–34. Exp Clin Endocrinol. 1993; 101: 150–5. doi: 10.1055/s-0029–1211222.
20. Bockaert J., Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 1999; 18 1723–1729. 10.1093/emboj/18.7.1723.
21. Boras-Granic K., Dann P., VanHouten J., Karaplis A., Wysolmerski J. Deletion of the Nuclear Localization Sequences and C-Terminus of PTHrP Impairs Embryonic Mammary Development but also Inhibits PTHrP Production. PLoS ONE. 2014; 9 (5): e90418. https://doi.org/10.1371/journal.pone.0090418.
22. Botella A., Rekik M., Delvaux M., Davicco M.J., Barlet J.P., Frexinos J., Bueno L. Parathyroid hormone (PTH) and PTH-related peptide induce relaxation of smooth muscle cells from guinea pig ileum: interaction with vasoactive intestinal peptide receptors. Endocrinology. 1994; 135 (5): 2160-7.
23. Bouizar Z., Spyratos F., De Vernejoul M.C. The parathyroid hormonerelatedprotein (PTHrP) gene: Use of downstream TATA promotor and PTHrP1–139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis. J Bone Miner Res. 1999; 14: 406–414.
24. Brenner D., Bago A.G., Gallatz K., Palkovits M., Usdin T.B., Dobolyi A. Tuberoinfundibular peptide of 39 residues in the embryonic and early postnatal rat brain. J Chem Neuroanat. 2008; 36: 59–68.
25. Broadus A.E., Stewart A.F. Parathyroid hormone-related protein structure, processing and physiological actions. The Parathyroids, Raven Press ed., New York. 1994; pp. 259-294.
26. Burtis W.J., Wu T., Bunch C. et al. Identification of a novel 17,000-dalton parathyroid hormone-like adenylatecyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem.1987; 262: 7151–7156.
27. Cabrera-Vera T.M., Vanhauwe J., Thomas T.O. et al. Insights into G protein structure, function, and regulation. EndocrRev. 2003; 24 (6): 765–781.
28. Calebiro D., Nikolaev V.O., Gagliani M.C., de Filippis T., Dees C., Tacchetti C., Persani L., Lohse M.J. Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLoS Biol. 2009; 7:e1000172.
29. Calvi L.M. and Schipan E. The PTH/PTHrP receptor in Jansen’s metaphyseal chondrodysplasia. J Endocrinol Invest. 2000; 23: 545–554.
30. Campos R.V., Zhang L., Drucker D.J. Differential expression of RNA transcripts encoding unique carboxy-terminal sequences of human parathyroid hormone-related peptide. Mol. Endocrinol. 1995. 8 (12): 1656–1666.
31. Campos R.V., Wang C. and Drucker D.J. Regulation of parathyroid hormonerelated peptide (PTHrP) gene transcription: cell- and tissue-specific promoter utilization mediated by multiple positive and negative cis-acting DNA elements, Mol. Endocrinol. 1992; 6: 1642–1652.
32. Canario A.V., Rotllant J., Fuentes J., Guerreiro P.M., Rita Teodosio H., Power D.M. et al. Novel bioactive parathyroid hormone and related peptides in teleost fish. FEBS Lett. 2006; 580: 291–9.
33. Cardoso J.C., Felix R.C., Power D.M. Nematode and arthropod genomes provide new insights into the evolution of class 2 B1 GPCRs. PLoS One. 2014; 9: e92220. doi: 10.1371/journal.pone.0092220.
34. Cardoso J.C., Pinto V.C., Vieira F.A., Clark M.S., Power D.M. Evolution of secretin family GPCR members in the metazoa. BMC Evol Biol. 2006; 6: 108.
35. Carman C.V., Benovic J.L. G-protein-coupled receptors: turn-ons and turn-offs. Curr. Opin. Neurobiol. 1998; 8: 335–344. 10.1016/S0959-4388 (98) 80058-5.
36. Carpenter B., Nehme R., Warne T., Leslie A.G., Tate C.G. Structure of the adenosine A(2A) receptor bound to an engineered G protein. Nature. 2016; 536: 104–107. 10.1038/nature18966.
37. Carter P.H., Juppner H., Gardella T.J. Studies of the N-terminal region of a parathyroid hormone-related peptide (1–36) analog: receptor subtype-selective agonists, antagonists, and photochemical cross-linking agents. Endocrin. 1999; 140 (11): 4972–4981.
38. Carter P.H., Petroni B.D., Gensure R.C., Schipani E., Potts J.T. Jr., and Gardella T.J. Selective and nonselective inverse agonists for constitutively active type-1 parathyroid hormone receptors: evidence for altered receptor conformations. Endocrinology. 2001; 142: 1534–1545.
39. Castro M., Dicker F., Vilardaga J.P., Krasel C., Bernhardt M., Lohse M.J. Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and beta-arrestins. Endocrinology. 2002 Oct; 143 (10): 3854-65.
40. Castro M., Nikolaev V.O., Palm D., Lohse M.J., Vilardaga J.-P. Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. Proc. Natl Acad. Sci. USA. 2005; 102: 16084–16089.
41. Cataisson C., Gordon J., Roussiere M., Abdalkhani A., Lindemann R., Dittmer J., Foley J. and Bouizar Z. Ets-1 Activates Parathyroid Hormone-Related Protein Gene Expression In Tumorigenic Breast Epithelial Cells. Molecular and Cellular Endocrinology. 2003; 204: 155-168.
42. Caulfield M.P., McKee R.L., Goldman M.E., Duong L.T., Fisher J.E., Gay C.T., DeHaven P.A., Levy J.J., Roubini E., Nutt R.F, et al. The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region. Endocrinology. 1990; 127: 83–87.
43. Chan G.K., Deckelbaum R.A., Bolivar I., Goltzman D., Karaplis A.C. PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway. Endocrinology. 2001; 142: 4900–4909.
44. Chattopadhyay N., Evliyaoglu C., Heese O., Carroll R., Sanders J., Black P., Brown E.M. Regulation of secretion of PTHrP by Ca2+-sensing receptor in human astrocytes, astrocytomas, and meningiomas. Am J Physiol Cell Physiol. 2000; 279: C691–C699.
45. Chen H.L., Demiralp B., Schneider A., Koh A.J., Silve C., Wang C.Y., McCauley L.K. Parathyroid hormone and parathyroid hormone-related protein exert both pro- and anti-apoptotic effects in mesenchymal cells. J. Biol. Chem. 2002; 277: 19374–19381. doi: 10.1074/jbc.M108913200.
46. Cheloha R.W., Gellman S.H., Vilardaga J.P., Gardella T.J. PTH receptor-1signalling-mechanistic insights and therapeutic prospects. Nat RevEndocrinol. 2015; 11 (12): 712–24.
47. Chilco P.J., Leopold V., Zajac J.D. Differential regulation of the parathyroid hormone-related protein gene P1 and P3 promoters by cAMP. Mol Cell Endocrinol. 1998; 138: 173–184.
48. Chirgwin J.M., Mohammad K.S., Guise T.A. Tumor-bone cellular interactions in skeletal metastases. J. Musculoskelet Neuronal. Interact. 2004; 4: 308–318.
49. Cho Y.M., Lewis D.A., Koltz P.F., Richard V., Gocken T.A., Rosol T.J., Konger R.L., Spandau D.F., Foley J. Regulation of parathyroid hormone-related protein gene expression by epidermal growth factor-family ligands in primary human keratinocytes. J. Endocrinol. 2004; 181: 179–190. doi: 10.1677/joe.0.1810179.
50. Chorev M. Parathyroid hormone 1 receptor: insights into structure and function. Receptors Channels. 2002; 8: 219–242.
51. Christie M., Chang C.W., Rona G. Smith K.M., Stewart A.G., Takeda A.A., Fontes M.R., Stewart M., Vertessy B.G., Forwood J.K., Kobe B. Structural biology and regulation of protein import into the nucleus. Journal of molecular biology. 2015; 428 (10 Pt A): 2060-2090. DOI: 10.1016/j.jmb.2015.10.023
52. Cingolani G., Bednenko J., Gillespie M.T., Gerace L. Molecular basis for the recognition of a nonclassical nuclear localization signal by importin β. Molecular cell. 2002; 10 (6): 1345-1353.
53. Clarke W.P. What’s for lunch at the conformational cafeteria? Mol Pharmacol. 2005; 67: 1819–1821.
54. Clemens T.L., Cormier S., Eichinger A. et al. Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br J Pharmacol. 2001; 134: 1113–1136.
55. Cohen F.E., Strewler G.J., Bradley M.S., Carlquist M., Nilsson M., Ericsson M., Ciardelli T.L., Nissenson R.A. Analogues of parathyroid hormone modified at positions 3 and 6. Effects on receptor binding and activation of adenylyl cyclase in kidney and bone. J BiolChem. 1991; 266 (3): 1997-2004.
56. Cornish J., Callon K.E., Nicholson G.C., Reid I.R. Parathyroid hormone-related protein-(107–139) inhibits bone resorption in vivo. Endocrinology 1997; 138: 1299–1304.
57. Couvineau A., Wouters V., Bertrand G., Rouyer C., Gerard B., Boon L.M., Grandchamp B., Vikkula M., Silve C. PTHR1 mutations associated with Ollier disease result in receptor loss of function. Hum Mol Genet. 2008; 17 (18): 2766–2775. doi: 10.1093/hmg/ddn176.
58. Cramer S.D., Chen Z., Peehl D.M. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: Inactivation of PTHrP-stimulated camp accumulation in mouse osteoblasts. J. Urol. 1996; 156: 526–531. doi: 10.1016/S0022-5347 (01) 65919-6.
59. Cupp M.E., Nayak S.K., Adem A.S., Thomsen W.J. Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways. J. Pharmacol. Exp. Ther. 2013; 345: 404–418. doi: 10.1124/jpet.112.199752.
60. Damian G. DSouza. The Parathyroid Hormone Family of Ligands and Receptors. AIMS Medical Science, 2015; 2 (3): 118-130. doi: 10.3934/medsci.2015.3.118.
61. Danks J.A., D’Souza D.G., Gunn H.J., Milley K.M., Richardson S.J. Evolution of the parathyroid hormone family and skeletal formation pathways. Gen Comp Endocrinol. 2011; 170 (1): 79-91. doi: 10.1016/j.ygcen.2010.10.023.
62. Danks J.A., Freeman A.N., Martin T.J. Historical Perspective and Evolutionary Origins of Parathyroid Hormone-Related Protein. Clinical Reviews in Bone and Mineral Metabolism. 2014; 12 (3): 104–118. doi: 10.1007/s12018-014-9163-8.
63. Danks J.A., Ho P.M., Notini A.J., Katsis F., Hoffmann P., Kemp B.E., Martin T.J., and Zajac J.D. Identification of a parathyroid hormone in the fish Fugu rubripes. J Bone Miner Res. 2003; 18: 1326–1331.
64. Danks J.A., Trivett M.K., Power D.M., Canario A.V., Martin T.J., Ingleton P.M. Parathyroid hormone-related protein in lower vertebrates. Clin Exp Pharmacol Physiol. 1998; 25: 750–752.
65. Datta N.S., Samra T.A., Mahalingam C.D., Datta T., Abou-Samra A.B. Role of PTH1r internalization in osteoblasts and bone mass using a phosphorylation-deficient knock-in mouse model. J. Endocrinol. 2010; 207: 355–365. doi: 10.1677/JOE-10-0227.
66. De Gortazar A.R., Alonso V., Alvarez-Arroyo M.V. et al. Transient exposure to PTHrP (107–139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro. Calcif Tissue Int. 2006; 79 (5): 360-369.
67. de Graaf C., Song G., Cao C., Zhao Q., Wang M.W., Wu B., Stevens R.C. Extending the structural view of classB GPCRs. Trends Biochem Sci. 2017; 42: 946–60. doi: 10.1016/j.tibs.2017.10.003.
68. Dean T., Linglart A., Mahon M.J., Bastepe M., Juppner H., Potts J.T., Jr., Gardella T.J. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1–15) radioligand for GalphaS-coupled receptor conformations. Molecular endocrinology Baltimore. 2006; 20: 931-943.
69. Dean T., Vilardaga J.P., Potts J.T., Jr., Gardella T.J. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Molecular endocrinology Baltimore. 2008; 22: 156-166.
70. Decker E., Stellzig-Eisenhauer A., Fiebig B.S., Rau C., Kress W., Saar K., Ruschendorf F., Hubner N., Grimm T., Weber B.H. PTHR1 loss-of-function mutations in familial, nonsyndromic primary failure of tooth eruption. Am J Hum Genet. 2008; 83: 781–786.
71. Deftos L.J., Burton D., Hastings R.H., Terkeltaub R., Hook V.Y. Comparative tissue distribution of the processing enzymes «prohormone thiol protease», and prohormone convertases 1 and 2, in human PTHrP-producing cell lines and mammalian neuroendocrine tissues. Endocrine. 2001; 15 (2): 217-24.
72. Della Penna K., Kinose F., Sun H., Koblan K.S., Wang H. Tuberoinfundibular peptide of 39 residues (TIP39): molecular structure and activity for parathyroid hormone 2 receptor. Neuropharmacology. 2003; 44: 141–53. doi: 10.1016/S0028-3908 (02) 00335-0.
73. Diefenbach-Jagger H., Brenner C., Kemp B.E., Baron W., McLean J., Martin T.J., Moseley J.M. Arg21 is the preferred kexin cleavage site in parathyroid-hormone-related protein. Eur J. Biochem. 1995; 229: 91–98. doi: 10.1111/j.1432–1033.1995.0091l.x.
74. Dittmer J., Gegonne A., Gitlin S.D., Ghysdael J., Brady J.N. Regulation of parathyroid hormone-related protein (PTHrP) gene expression. Sp1 binds through an inverted CACCC motif and regulates promoter activity in cooperation with Ets1. J Biol Chem. 1994; 269 (34): 21428-34.
75. Dittmer J., Pise-Masison C.A., Clemens K.E., Choi K.S., Brady J.N. Interaction of human T-cell lymphotropic virus type I Tax, Ets1, and Sp1 in transactivation of the PTHrP P2 promoter. J Biol Chem. 1997; 272: 4953–4958.
76. Dobolyi A., Ueda H., Uchida H., Palkovits M., Usdin T.B. Anatomical and physiological evidence for involvement of tuberoinfundibular peptide of 39 residues in nociception. Proc Natl Acad Sci U S A. 2002; 99: 1651–1656.
77. Dobolyi A., Wang J., Irwin S., Usdin T.B. Postnatal development and gender-dependent expression of TIP39 in the rat brain. J Comp Neurol. 2006; 498: 375–389.
78. Dobolyi A., Dimitrov E., Palkovits M., Usdin T.B. The neuroendocrine functions of the parathyroid hormone 2 receptor. Front Endocrinol. 2012; 3: 121.10.3389/fendo.2012.00121.
79. Dobolyi A., Palkovits M., Usdin T.B. Expression and distribution of tuberoinfundibular peptide of 39 residues in the rat central nervous system.
J Comp Neurol. 2003; 455: 547–566.
80. Dobolyi A., Palkovits M., Usdin T.B. The TIP39-PTH2 receptor system: unique peptidergic cell groups in the brainstem and their interactions with central regulatory mechanisms. Prog Neurobiol. 2010 11; 90 (1): 29-59. doi: 10.1016/j.pneurobio.2009.10.017.
81. Dong S., Shang S., Li J., Tan Z., Dean T., Maeda A., Gardella T.J., Danishefsky S.J. Engineering of therapeutic polypeptides through chemical synthesis: early lessons from human parathyroid hormone and analogues. J Am Chem Soc. 2012; 134: 15122–15129.
82. Duchatelet S., Ostergaard E., Cortes D., Lemainque A., Julier C. Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes. Hum Mol Genet. 2005; 14 (1): 1–5.
83. Duval C., Dilworth M.R., Tunsterc S.J., Kimber S.J., Glazier J.D. PTHrP is essential for normal morphogenetic and functional development of the murine placenta. Developmental Biology. 2017; 430 (2): 325-336.
84. Ehrenmann J., Schoppe J., Klenk C., Rappas M., Kummer L., Dore A.S., Pluckthun A. High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist. Nat Struct Mol Biol. 2018; 25, 1086–1092. doi: 10.1038/s41594-018-0151-4.
85. Eichel K., von Zastrow M. Subcellular organization of GPCR signaling. Trends Pharmacol Sci. 2018; 39: 200–208.
86. Eichinger A., Fiaschi-Taesch N., Massfelder T., Fritsch S., Barthelmebs M., Helwig J.J. Transcript expression of the tuberoinfundibular peptide (TIP) 39/PTH2 receptor system and non-PTH1 receptor-mediated tonic effects of TIP39 and other PTH2 receptor ligands in renal vessels. Endocrinology. 2002; 143 (8): 3036–3043.
87. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011; 12: 861–874.
88. Faber C.A., Dobolyi A., Sleeman M., Usdin T.B. Distribution of tuberoinfundibular peptide of 39 residues and its receptor, parathyroid hormone 2 receptor, in the mouse brain. J Comp Neurol. 2007; 502: 563–583.
89. Fegley D.B., Holmes A., Riordan T., Faber C.A., Weiss J.R., Ma S., Batkai S., Pacher P., Dobolyi A., Murphy A., Sleeman M.W., Usdin T.B. Increased fear- and stress-related anxiety-like behavior in mice lacking tuberoinfundibular peptide of 39 residues. Genes Brain Behav. 2008; 7: 933–942.
90. Feinstein T.N., Wehbi V.L., Ardura J.A., Wheeler D.S., Ferrandon S., Gardella T.J., and Vilardaga J.P. Retromer terminates the generation of cAMP by internalized PTH receptors. Nat Chem Biol. 2011; 7: 278–284.
91. Fenton A.J., Kemp B.E., Kent G.N., Moseley J.M., Zheng M.H., Rowe D.J., Britto J.M., Martin T.J., Nicholson G.C. A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts. Endocrinology 1991; 129: 1762–1768.
92. Ferrandon S., Feinstein T.N., Castro M., Wang B., Bouley R., Potts J.T., Gardella T.J., and Vilardaga J.P. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol. 2009; 5: 734–742.
93. Ferrari S., Behar V., Chorev M., Rosenblatt M., Bisello A. Endocytosis of ligand-human parathyroid hormone receptor 1 complexes is protein kinase C-dependent and involves beta-arrestin2. Real-time monitoring by fluorescence microscopy. J Biol. Chem. 1999; 274: 29968–29975.
94. Ferrari S.L. and Bisello A. Cellular distribution of constitutively active mutant parathyroid hormone (PTH)/PTH-related protein receptors and regulation of cyclic adenosine 39,59-monophosphate signaling by beta-arrestin2. Mol Endocrinol. 2001; 15: 149–163.
95. Fiaschi-Taesch N.M., Stewart A.F. Minireview: parathyroid hormone-related protein as an intracrine factor–trafficking mechanisms and functional consequences. Endocrinology. 2003; 144: 407–411.
96. Fingleton B., Lynch C.C. A new dress code for mmps: Cleavage optional. Dev. Cell. 2010; 18: 3–4. doi: 10.1016/j.devcel.2010.01.003; 112. Lopez-Otin C., Overall C.M. Protease degradomics: A new challenge for proteomics. Nat. Rev. Mol. Cell Biol. 2002; 3: 509–519. doi: 10.1038/nrm858.
97. Foley J., Wysolmerski J.J., Missero C., King C.S., Philbrick W.M. Regulation of parathyroid hormone-related protein gene expression in murine keratinocytes by E1A isoforms: a role for basal promoter and Ets-1 site. Mol Cell Endocrinol. 1999; 156: 13–23.
98. Fortelny N., Cox J.H., Kappelhoff R., Starr A.E., Lange P.F., Pavlidis P., Overall C.M. Network analyses reveal pervasive functional regulation between proteases in the human protease web. PLoS Biol. 2014; 12:e1001869. doi: 10.1371/journal.pbio.1001869.
99. Frazier-Bowers S.A., Simmons D., Wright J.T., Proffit W.R., Ackerman J.L. Primary failure of eruption and PTH1R: the importance of a genetic diagnosis for orthodontic treatment planning. Am J Orthod Dentofacial Orthop. 2010; 137: 160 e161–167; discussion 160–161.
100. Fredriksson R., Lagerstrom M.C., Lundin L.G., Schioth H.B. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 2003; 63: 1256–1272. 10.1124/mol.63.6.1256.
101. Friedman P.A., Gesek F.A., Morley P., Whitfield J.F., Willick G.E. Cell-specific signaling and structure-activity relations of parathyroid hormone analogs in mouse kidney cells. Endocrinology. 1999; 140: 301–309.
102. Frieling J.S., Lynch C.C. Proteolytic Regulation of Parathyroid Hormone-Related Protein: Functional Implications for Skeletal Malignancy. Int J Mol Sci. 2019 Jun 8; 20 (11): 2814. doi: 10.3390/ijms20112814.
103. Frieling J.S., Shay G., Izumi V., Aherne S.T., Saul R.G., Budzevich M., Koomen J., Lynch C.C. Matrix metalloproteinase processing of PTHrP yields a selective regulator of osteogenesis, PTHrP1–17. Oncogene. 2017 doi: 10.1038/onc.2017.70.
104. Fukayama S., Tashjian A.H.Jr., Davis J.N., Chisholm J.C. Signaling by N- and Cterminal sequences of parathyroid hormone-related protein in hippocampal neurons. Proc Natl Acad Sci USA. 1995; 92: 10182–10186.
105. Funk J.L., Wei H. Regulation of parathyroid hormone-related protein expression in MCF-7 breast carcinoma cells by estrogen and antiestrogens. Biochem Biophys Res Commun. 1998; 251: 849–854.
106. Gaich G., Orloff J.J., Atillasoy E.J., Burtis W.J., Ganz M.B., Stewart A.F. Aminoterminal parathyroid hormone-related protein: specific binding and cytosolic calcium responses in rat insulinoma cells. Endocrinology 1993; 132: 1402–1409.
107. Gardella T.J, Luck M.D., Jensen G.S., Usdin T.B., Juppner H. Converting Parathyroid Hormone-related Peptide (PTHrP) into a Potent PTH-2 Receptor Agonist The Journal of Biological Chemistry. 1996; 271: 19888-19893.
108. Gardella T.J., Juppner H. Molecular properties of the PTH/PTHrP receptor. Trends EndocrinolMetab. 2001; 12 (5): 210-217.
109. Gardella T.J., Luck M.D., Wilson A.K., Keutmann H.T., Nussbaum S.R., Potts J.T. Jr, Kronenberg H.M. Parathyroid hormone (PTH)-PTH-related peptide hybrid peptides reveal functional interactions between the 1–14 and 15-34 domains of the ligand. J Biol Chem. 1995; 270 (12): 6584-8.
110. Gardella T.J., Vilardaga J.P. International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors-family B G protein-coupled receptors. Pharmacol Rev. 2015; 67 (2): 310-337.
111. Gelbert L., Schipani E., Juppner H., Abou-Samra A.B., Segre G.V., Naylor S., Drabkin H., Heath H. 3rd. Chromosomal localization of the parathyroid hormone/parathyroid hormone-related protein receptor gene to human chromosome 3p21.1-p24.2. J Clin Endocrinol Metab. 1994; 79 (4): 1046-8.
112. Gensure R.C., Gardella T.J., Ju ppner H.: Parathyroid hormone and parathyroid hormonerelated peptide, and their receptors. Biochem Biophys Res Commun. 2005, 328 (3): 666-678.
113. Gensure R.C., Ponugoti B., Gunes Y., Papasani M.R., Lanske B., Bastepe M., Rubin D.A., Juppner H. Identification and characterization of two parathyroid hormone-like molecules in zebrafish. Endocrinology. 2004; 145: 1634–1639.
114. Gesty-Palmer D., Chen M., Reiter E., Ahn S., Nelson C.D., Wang S., Eckhardt A.E., Cowan C.L., Spurney R.F., Luttrell L.M. et al. Distinct beta-arrestin- and g protein-dependent pathways for parathyroid hormone receptor-stimulated erk1/2 activation. J. Biol. Chem. 2006; 281: 10856–10864. doi: 10.1074/jbc.M513380200.
115. Gidon A., Al-Bataineh M.M., Jean-Alphonse F.G., Stevenson H.P., Watanabe T., Louet C., Khatri A., Calero G., Pastor-Soler N.M., Gardella T.J. et al. Endosomal GPCR signaling turned off by negative feedback actions of PKA and v-ATPase. Nat Chem Biol. 2014; 10: 707–709.
116. Gillespie M.T. and Martin T.J. The parathyroid hormone-related protein gene and its expression. Mol. Cell Endocrinol.1994; 100: 143–147.
117. Glatz J.A., Heath J.K., Southby J. O’Keeffe L.M., Takeshi K., Moseley J.M., Martin T.J., Gillespie, M.T. Dexamethasone regulation of parathyroid hormone-related protein (PTHrP) expression in a squamous cancer cell line. Mol Cell Endocrinol. 1994; 101: 295–306.
118. Goomer R.S., Shen X., Falzon M. et al. The tetrabasic KKKK(147–150) motif determines intracrine regulatory effects of PthrP 1–173 on chondrocyte PPi metabolism and matrix synthesis. Endocrin. 2000; 141 (12): 4613-4622.
119. Guerreiro P.M., Renfro J.L., Power D.M., Canario A.V. The parathyroid hormone family of peptides: structure, tissue distribution, regulation, and potential functional roles in calcium and phosphate balance in fish. Am J PhysiolRegulIntegr Comp Physiol. 2007; 292 (2): 679-696.
120. Gurevich V.V., Gurevich E.V. The molecular acrobatics of arrestin activation. Trends Pharmacol. Sci. 2004; 25: 105–111. 10.1016/j.tips.2003.12.008.
121. Gurevich V.V., Gurevich E.V. GPCR Signaling Regulation: The Role of GRKs and Arrestins. Front. Pharmacol. 2019; 10: 125. doi: 10.3389/fphar.2019.00125.
122. Hang X.M., Power D., Flik G., Balment R.J. Measurement of PTHrP, PTHR1, and CaSR expression levels in tissues of sea bream (Sparus aurata) using quantitative PCR. Ann NYAcad Sci. 2005; 1040: 340–344.
123. Hansen I.A., Jakob O., Wortmann S., Arzberger T., Allolio B., Blind E. Characterization of the human and mouse genes encoding the tuberoinfundibular peptide of 39 residues, a ligand of the parathyroid hormone receptor family. J Endocrinol. 2002; 174: 95–102.
124. Haq M., Kremer R., Goltzman D. Rabbani S.A. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo. J Clin Invest 1993; 91: 2416–2422.
125. Harmar A.J. Family-B G-protein-coupled receptors. Genome Biol. 2001; 2: 30131–30110.
126. Harvey S., Hayer S., Sloley B.D. Parathyroid hormone-induced dopamine turnover in the rat medial basal hypothalamus. Peptides. 1993; 14: 269–74.
127. Heath J.K., Southby J., Fukumoto S., O’Keeffe L.M., Martin T.J., Gillespie M.T. Epidermal growth factor-stimulated parathyroid hormone-related protein expression involves increased gene transcription and mrna stability. Biochem. J. 1995; 307: 159–167. doi: 10.1042/bj3070159.
128. Hendy G.N., Bennett H.P., Gibbs B.F., Lazure C., Day R., Seidah N.G. Proparathyroid hormone is preferentially cleaved to parathyroid hormone by the prohormone convertase furin. A mass spectrometric study. J. Biol. Chem. 1995; 270: 9517–9525. doi: 10.1074/jbc.270.16.9517.
129. Hoare S.R., Bonner T.I., Usdin T.B. Comparison of rat and human parathyroid hormone 2 (PTH2) receptor activation: PTH is a low potency partial agonist at the rat PTH2 receptor. Endocrinology. 1999; 140: 4419–4425.
130. Hoare S.R., Clark J.A., Usdin T.B. Molecular determinants of tuberoinfundibular peptide of 39 residues (TIP39) selectivity for the parathyroid hormone-2 (PTH2) receptor. N-terminal truncation of TIP39 reverses PTH2 receptor/PTH1 receptor binding selectivity. J Biol Chem. 2000a; 275: 27274–27283.
131. Hoare S.R., Rubin D.A., Juppner H., Usdin T.B. Evaluating the ligand specificity of zebrafish parathyroid hormone (PTH) receptors: comparison of PTH, PTH-related protein, and tuberoinfundibular peptide of 39 residues. Endocrin. 2000b; 141 (9): 3080–3086.
132. Hoare S.R., Usdin T.B. Tuberoinfundibular peptide (7–39) [TIP(7–39)], a novel, selective, high-affinity antagonist for the parathyroid hormone-1 receptor with nodetectable agonist activity. J Pharmacol Exp Ther. 2000; 295: 761–770.
133. Hoare S.R., Usdin T.B., Molecular mechanisms of ligand recognition by parathyroid hormone 1 (PTH1) and PTH2 receptors. Curr Pharm Des. 2001; 7: 689–713.
134. Hoare S.R., Usdin T.B. Specificity and stability of a new PTH1 receptor antagonist, mouse TIP(7–39). Peptides. 2002; 23: 989–998.
135. Hoare, S.R., Gardella, T.J., Usdin, T.B. Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor. Effect of receptor-G-protein interaction on the ligand binding mechanism and receptor conformation. The Journal of biological chemistry. 2001; 276: 7741-7753.
136. Hogan B.M., Danks J.A., Layton J.E., Hall N.E., Heath J.K., and Lieschke G.J. Duplicate zebrafish pth genes are expressed along the lateral line and in the central nervous system during embryogenesis. Endocrinology/ 2005; 146: 547–551.
137. Hoogendam J., Farih-Sips H., Wynaendts L.C., Lowik C.W., Wit J.M., and Karperien M. Novel mutations in the parathyroid hormone (PTH)/PTH-related peptide receptor type 1 causing Blomstrand osteochondrodysplasia types I and II. J Clin Endocrinol Metab. 2007; 92: 1088–1095.
138. Hook V.Y., Burton D., Yasothornsrikul S., Hastings R.H., Deftos L.J. Proteolysis of proPTHrP(1–141) by «prohormone thiol protease» at multibasic residues generates PTHrP-related peptides: Implications for PTHrP peptide production in lung cancer cells. Biochem. Biophys Res. Commun. 2001; 285: 932–938. doi: 10.1006/bbrc.2001.5249.
139. Hopyan S., Gokgoz N., Poon R., Gensure R.C. et al. A mutant PTH/PTHrP type I receptor in enchondromatosis. Nat Genet. 2002; 30: 306-310. 10.1038/ng844.
140. Horwitz M.J., Tedesco M.B., Gundberg C., Garcia-Ocana A., Stewart A.F. Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab. 2003; 88: 569–575.
141. Horwitz M.J., Tedesco M.B., Sereika S.M., Garcia-Ocana A., Bisello A., Hollis B.W., Gundberg C., Stewart A.F. Safety and tolerability of subcutaneous PTHrP(1–36) in healthy human volunteers: a dose escalation study. Osteoporos Int. 2006; 17: 225–230.
142. Horwitz M.J., Tedesco M.B., Sereika S.M., Syed M.A., Garcia-Ocana A., Bisello A., Hollis B.W., Rosen C.J., Wysolmerski J.J., Dann P., Gundberg C., Stewart A.F. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25 (OH)2 vitamin D. J Bone Miner Res. 2005; 20: 1792–1803.
143. Hwang J.I., Moon M.J., Park S., Kim D.K., Cho E.B., Ha N., Son G.H., Kim K., Vaudry H., Seong J.Y. Expansion of secretin-like G protein-coupled receptors and their peptide ligands via local duplications before and after two rounds of whole-genome duplication. Mol Biol EVol. 2013; 30: 1119–30.
144. Ikeda K., Lu C., Weir E.C., Mangin M., Broadus A.E. Transcriptional regulation of the parathyroid hormone-related peptide gene by glucocorticoids and vitamin D in a human C-cell line. J Biol Chem. 1989; 264 (27): 15743-15746.
145. Irannejad R. and von Zastrow M. GPCR signaling along the endocytic pathway. Curr Opin Cell Biol. 2014; 27: 109–116.
146. Jans D.A., Thomas R.J., Gillespie M.T. Parathyroid hormone-related protein (PTHrP): a nucleocytoplasmic shuttling protein with distinct paracrine and intracrine roles. Vitam Horm. 2003; 66: 345–384.
147. Jansen M. Uber atypische Chondrodystrophie (Achondroplasie) und uber eine noch nicht beschriebene angeborene Wachstumsstorung des Knochensystems: Metaphysare Dysostosis. Zeitschr Orthop Chir. 1934; 61: 253–286.
148. Jobert A.S., Zhang P., Couvineau A., Bonaventure J., Roume J., Le Merrer M., and Silve C. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest. 1998; 102: 34–40. 10.1172/ JCI2918 [doi].
149. John M.R., Arai M., Rubin D.A., Jonsson K.B., Juppner H. Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues. Endocrinology. 2002; 143 (3): 1047–1057.
150. Johnson R.W., Nguyen M.P., Padalecki S.S., Grubbs B.G., Merkel A.R., Oyajobi B.O., Matrisian L.M., Mundy G.R., Sterling J.A. Tgf-beta promotion of gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical hedgehog signaling. Cancer Res. 2011; 71: 822–831. doi: 10.1158/0008-5472.CAN-10-2993.
151. Jonsson K.B., John M.R., Gensure R.C., Gardella T.J., and Juppner H. Tuberoinfundibular peptide 39 binds to the parathyroid hormone (PTH)/PTH-related peptide receptor, but functions as an antagonist. Endocrinology. 2001; 142 (2): 704–709.
152. Juppner H. Receptors for parathyroid hormone and parathyroid hormone-related peptide: exploration of their biological importance. Bone. 1999; 25: 87–90.
153. Juppner H., Abou-Samra A.B., Freeman M. et al. A G-protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science. 1991; 254 (5034): 1024-1026.
154. Juppner H., Abou-Samra A.B., Uneno S., Gu W.X., Potts J.T. Jr., Segre G.V. The parathyroid hormone-like peptide associated with humoral hypercalcemia of malignancy and parathyroid hormone bind to the same receptor on the plasma membrane of ROS 17/2.8 cells. J Biol Chem. 1988; 263: 8557–8560.
155. Kakonen S.M., Selander K.S., Chirgwin J.M. Yin J.J., Burns S., Rankin W.A., Grubbs B.G., Dallas M., Cui Y., Guise T.A. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways. J Biol Chem 2002; 277 (27): 24, 571–578.
156. Kamesh N., Aradhyam G.K., and Manoj N. The repertoire of G protein-coupled receptors in the sea squirt Ciona intestinalis. BMC Evol Biol. 2008; 8: 129. doi: 10.1186/1471–2148-8-129.
157. Kappelhoff R., Puente X.S., Wilson C.H., Seth A., Lopez-Otin C., Overall C.M. Overview of transcriptomic analysis of all human proteases, non-proteolytic homologs and inhibitors: Organ, tissue and ovarian cancer cell line expression profiling of the human protease degradome by the clip-chip DNA microarray. Biochim. Biophys. Acta Mol. Cell Res. 2017; 1864: 2210–2219. doi: 10.1016/j.bbamcr.2017.08.004.
158. Karaplis A.C., He B., Nguyen M.T., Young I.D., Semeraro D., Ozawa H., and Amizuka N. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology. 1998; 139: 5255–5258.
159. Karperien M., van der Harten H.J., van Schooten R., Farih-Sips H., den Hollander N.S., Kneppers S.L., Nijweide P., Papapoulos S.E., and Lowik C.W. A frame-shift mutation in the type I parathyroid hormone (PTH)/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia. J Clin Endocrinol Metab. 1999; 84: 3713–3720.
160. Kasono K., Isozaki O., Sato K. Sato Y., Shizume K., Ohsumi K., Demura H. Effects of glucocorticoids and calcitonin on parathyroid hormone-related protein (PTHrP) gene expression and PTHrP release in human cancer cells causing humoral hypercalcemia. Jpn J Cancer Res. 1991; 82 (9): 1008-1014.
161. Kotowski S.J., Hopf F.W., Seif T., Bonci A., von Zastrow M. Endocytosis promotes rapid dopaminergic signaling. Neuron. 2011; 71: 278–290.
162. Kovacs C.S., Ho-Pao C.L., Hunzelman J.L., Lanske B., Fox J., Seidman J.G., Seidman C.E., Kronenberg H.M. Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor. J Clin Invest. 1998; 101: 2812–2820.
163. Kremer R., Karaplis A.C., Henderson J.E. et al. Regulation of parathyroid hormonelike peptide in cultured normal human keratinocytes. J Clin Invest 1991; 87: 884–893.
164. Kronenberg H.M. PTHrP and skeletal development. Ann. N.Y. Acad. Sci. 2006; 1068: 1–13.
165. Kunakornsawat S., Rosol T.J., Capen C.C. et al. Effects of 1,25 (OH)2D3, EB1089, and analog V on PTHrP production, PTHrP mRNA expression and cell growth in SCC 2/88. Anticancer Res. 2001; 21 (5): 3355-3363.
166. Kuo J. and Usdin T.B. Development of a rat parathyroid hormone 2 receptor antagonist. Peptides.2007; 28: 887–892.
167. La Buda C.J., Dobolyi A., Usdin T.B. Tuberoinfundibular peptide of 39 residues produces anxiolytic and antidepressant actions. Neuroreport. 2004; 15: 881–885.
168. La Buda C.J., Usdin T.B. Tuberoinfundibular peptide of 39 residues decreases pain-related affective behavior. Neuroreport. 2004; 15: 1779–1782.
169. Lam M.H., Briggs L.J., Hu W., Martin T.J., Gillespie M.T., Jans D.A. Importin beta recognizes parathyroidhormone-related protein with high affinity and mediates its nuclear import in the absence of importin-alpha. J Biol Chem 1999; 274: 7391–7380.
170. Lam M.H., Thomas R.J., Martin T.J. et al. Nuclear and nucleolar localization of parathyroid hormone-related protein. Immunol. CellBiol. – 2000; 78 (4): 395–402.
171. Lanske B., Divieti P., Kovacs C.S. Pirro A., Landis W.J., Krane S.M., Bringhurst F.R., Kronenberg H.M. The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands inmurine bone. Endocrinology.1998; 139: 5194–5204.
172. Lanske B., Karaplis A.C., Lee K., Luz A., Vortkamp A., Pirro A., Karperien M., Defize L.H., Ho C., Mulligan R.C., Abou-Samra A.B., Juppner H., Segre G.V., Kronenberg H.M. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science. 1996; 273: 663–666.
173. Li H., Seitz P.K., Thomas M.L., Selvanayagam P., Rajaraman S., Cooper C.W. Widespread expression of the parathyroid hormone-related peptide and PTH/PTHrP receptor genes in intestinal epithelial cells. Lab Invest. 1995; 73: 864–870.
174. Li J., Dong S., Townsend S.D., Dean T., Gardella T.J., Danishefsky S.J. Chemistry as an expanding resource in protein science: fully synthetic and fully active human parathyroid hormone-related protein (1–141). Angew Chem Int Ed Engl. 2012; 51: 12263–12267.
175. Li T.F., Dong Y., Ionescu A.M., Rosier R.N., Zuscik M.J., Schwarz E.M., O’Keefe R.J., Drissi H. Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathway. Exp Cell Res. 2004; 299 (1): 128-136.
176. Liang Y.L., Khoshouei M., Radjainia M., Zhang Y., Glukhova A., Tarrasch J. et al. Phase-plate cryo-EM structure of a class B GPCR-G-protein complex. Nature. 2017; 546: 118–123. 10.1038/nature22327.
177. Liu B., Goltzman D., Rabbani S.A. Processing of pro-PTHrP by the prohormone convertase, furin: Effect on biological activity. Am. J. Physiol. 1995; 268: E832–E838. doi: 10.1152/ajpendo.1995.268.5.E832.
178. Liu J., Qian L.D., Huo J.L., B.L. Bi, D.L. Li, S.F. Wang, T. Chen5, L.J. Li, H.M. Mao., Y.W. Miao. Identification, molecular characterization, and tissue expression of parathyroid hormone-related protein gene (PTHrP) from water buffalo (Bubalus bubalis). Genetics and Molecular Research. 2015; 14 (1): 2290-2301.
179. Liu Y., Ibrahim A.S., Tay B. Richardson S.J., Bell J., Walker T.I., Brenner S., Venkatesh B., Danks J.A. Parathyroid hormone gene family in acartilaginous fish, the elephant shark (Callorhinshus milii). J Bone Miner Res. 2010; 25: 2613–2623.
180. Lopez-Otin C., Bond J.S. Proteases: Multifunctional enzymes in life and disease. J. Biol. Chem. 2008; 283: 30433–30437. doi: 10.1074/jbc.R800035200.
181. Luck M.D., Carter P.H., Gardella T.J. The (1–14) fragment of parathyroid hormone (PTH) activates intact and amino-terminally truncated PTH-1 receptors. Mol Endocrinol. 1999; 13 (5): 670–680.
182. Luparello C. Midregion PTHrP and human breast cancer cells. Sci. World J. 2010; 10: 1016–1028.
183. Luparello C. Parathyroid Hormone-Related Protein (PTHrP): A Key Regulator of Life/Death Decisions by Tumor Cells with Potential Clinical Applications Cancers. 2011; 3: 396-407.
184. Lupp A., Klenk C., Rocken C. et al. Immunohistochemical dentification of the PTHR1 parathyroid hormone receptor in normal and neoplastic human tissues. European Journal of Endocrinology. 2010; 162: 979–986.
185. Luttrell L.M. Minireview: More than just a hammer: ligand “bias” and pharmaceutical discovery. Mol Endocrinol. 2014; 28: 281–294.
186. Maeda A., Okazaki M., Baron D.M., Dean T., Khatri A., Mahon M., Segawa H., Abou-Samra A.B., Juppner H., Bloch K.D. et al. Critical role of parathyroid hormone (PTH) receptor-1 phosphorylation in regulating acute responses to PTH. Proc Natl Acad Sci USA. 2013; 110: 5864–5869.
187. Mahon M.J., Donowitz M., Yun C.C., Segre G.V. Na(+)/H(+) exchanger regulatory factor 2 directs parathyroid hormone 1 receptor signalling. Nature 2002; 417: 858–861.
188. Mahon M.J., Cole J.A., Lederer E.D., and Segre G.V. Na+/H+ exchanger-regulatory factor 1 mediates inhibition of phosphate transport by parathyroid hormone and second messengers by acting at multiple sites in opossum kidney cells. Mol Endocrinol. 2003; 17: 2355–2364.
189. Maguer-Satta V., Besancon R., Bachelard-Cascales E. Concise review: Neutral endopeptidase (cd10): A multifaceted environment actor in stem cells, physiological mechanisms, and cancer. Stem Cells. 2011; 29: 389–396. doi: 10.1002/stem.592
190. Malecz N., Bambino T., Bencsik M., and Nissenson R.A. Identification of phosphorylation sites in the G protein-coupled receptor for parathyroid hormone. Receptor phosphorylation is not required for agonist-induced internalization. Mol Endocrinol. 1998; 12: 1846–1856.
191. Mamonova T., Kurnikova M., Friedman P.A. Structural basis for NHERF1 PDZ domain binding. Biochemistry. 2012; 51: 3110–3120.
192. Mangin M. K. Ikeda B.E., Broadus A.E. Identification of an up-stream promoter of the human parathyroid hormone-related peptide gene Mol Endocrinol. 1990; 4: 851–858.
193. Mangin M., Ikeda K., Broadus A.E. Structure of the mouse gene encoding parathyroid hormone-related peptide. Gene. 1990; 95: 195–202.
194. Mangin M., Ikeda K., Dreyer B.E. Broadus A.E. Isolation and characterization of the human parathyroid hormone-like peptide gene. Proc. Natl. Acad. Sci. U.S.A. 1989; 86 (7): 2408–2412.
195. Mangin M., Ikeda K., Dreyer B.E., Milstone L., Broadus A.E. Two distinct tumorderived, parathyroid hormone-like peptides result from alternative ribonucleic acid splicing. Mol Endocrinol. 1988; 2: 1049–1055.
196. Mannstadt M., Clarke B.L., Vokes T., Brandi M-L., Ranganath L., Fraser W.D., Lakatos P., Bajnok L., Garceau R., Mosekilde L. et al. Efficacy and safety of recombinant human parathyroid hormone (1–84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol. 2013; 1: 275–283.
197. Mannstadt M., Juppner H., Gardella T.J. Receptors for PTH and PTHrP. Am. J. Physiol. 1999; 277: 665–675.
198. Manring M.M., Calhoun J.H. Biographical sketch: Fuller Albright, MD 1900– 1969. Clin. Orthop. Relat. Res. 2011; 469 (8): 2092–2095.
199. Martin T.J., Allan E.H., Caple I.W., Care A.D. et al. Parathyroid hormonerelated protein: isolation, molecular cloning, and mechanism of action. Recent Prog. Horm. Res. 1989; 45: 467-502; discussion 502-506.
200. Martin T.J., Moseley J.M., Williams E.D. Parathyroid hormone–related protein: hormone and cytokine. J Endocrinol.1997; 154: 23–37.
201. Martin T.J. Parathyroid Hormone-Related Protein, Its Regulation of Carti-lage and Bone Development, and Role in Treating Bone Diseases. Physiological Reviews. 2016; 96 (3): 831–871.
202. Mattick J.S. The genetic signatures of noncoding RNAs. PLoS Genet.2009; 5: e1000459.
203. McCauley L.K., Martin T.J. Twenty-five years of PTHrP progress: From cancer hormone to multifunctional cytokine. J Bone Miner Res. 2012; 27: 1231–1239.
204. McCauley L.K., Rosol T.J., Merryman J.I., Capen C.C. Parathyroid hormone-related protein binding to human T-cell lymphotropic virus type I-infected lymphocytes. Endocrinology. 1992; 130: 300–306.
205. Miao D., Su H., He B., Gao J., Xia Q., Zhu M., Gu Z., Goltzman D., Karaplis A.C. Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein. Proc Natl Acad Sci U S A. 2008; 105: 20309–20314.
206. Miao D., Tong X.K., Chan G.K., Panda D., McPherson P.S., Goltzman D. Parathyroid hormone-related peptide stimulates osteogenic cell proliferation through protein kinase C activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem. 2001; 276: 32204–32213.
207. Miao D., He B., Jiang Y., Kobayashi T., Soroceanu M.A., Zhao J., Su H., Tong X., Amizuka N., Gupta A. et al. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1–34. J. Clin. Invest. 2005; 115: 2402–2411. doi: 10.1172/JCI24918
208. Mierke D.F., Mao L., Pellegrini M., Piserchio A., Plati J., Tsomaia N. Structural characterization of the parathyroid hormone receptor domains determinant for ligand binding. Biochem Soc Trans. 2007; 35: 721–723.
209. Moirangthem A., Narayanan D.L., Jacob P., Nishimura G., Mortier G., Girisha K.M. Report of second case and clinical and molecular characterization of Eiken syndrome. Clin Genet. 2018; 94: 457–460. doi: 10.1111/cge.13413.
210. Mokrysheva N.G., Krupinova J.A., Kovaleva E.V. The Parathyroid Hormone and Peptides Like It. Literature Review // Annals of the Russian academy of medical sciences. – 2019. – Т. 74. – № 2. – C. 136-144. doi: 10.15690/vramn1104.
211. Moseley J.M., Gillespie M.T. Parathyroid hormone-related protein. Crit Rev Clin Lab Sci. 1995; 32: 299–343. doi: 10.3109/10408369509084687.
212. Moseley J.M., Kubota M., Diefenbach-Jagger H., Wettenhall R.E., Kemp B.E., Suva L.J., Rodda C.P., Ebeling P.R., Hudson P.J., Zajac J.D. et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. PNAS. 1987; 84: 5048–5052.
213. Naafs M.A.B. Parathyroid hormone related peptide (PTHrP): a mini-review. Endocrinol Metab Int J. 2017; 5 (6): 321 328. DOI: 10.15406/emij.2017.05.00139.
214. Ng S.Y.L., Chow B.K.C., Kasamatsu J., Kasahara M., Lee L.T.O. Agnathan VIP, PACAP and Their Receptors: Ancestral Origins of Today’s Highly Diversified Forms. PLoS ONE. 2012; 7 (9): e44691. doi.org/10.1371/journal.pone.0044691.
215. Nishishita T., Okazaki T., Ishikawa T., Igarashi T., Hata K., Ogata E., Fujita T. A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D. J Biol Chem. 1998; 273: 10901–10907.
216. Noda H., Guo J., Khatri A., Dean T., Reyes M., Armanini M., Brooks D.J., Martins J.S., Schipani E., Bouxsein M.L., Demay M.B., Potts J.T., Jr, Juppner H. and Gardella T.J. An Inverse Agonist Ligand of the PTH Receptor Partially Rescues Skeletal Defects in a Mouse Model of Jansen’s Metaphyseal Chondrodysplasia. J Bone Miner Res. 2020; doi: 10.1002/jbmr.3913.
217. Nutt R.F., Caulfield M.P., Levy J.J., Gibbons S.W., Rosenblatt M., McKeeet R.L. Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7–34)NH2 by substitution of PTH amino acids at positions 10 and 11. Endocrin. 1990; 127 (1): 491-493.
218. Ogata N. Cytokines in bone diseases. Genetic defects of PTH/PTHrP receptor in chondrodysplasia. Clin Calcium. 2010; 20 (10): 1481–8. doi: CliCa10101481148.
219. Ohguchi H., Mitsui R., Imaeda K. Joh T., Hashitani H. Mechanisms of PTHrP-induced inhibition of smooth muscle contractility in the guinea pig gastric antrum. Neurogastroenterol Motil. 2017; 29 (12). doi: 10.1111/nmo.13142. http://dx.doi.org/10.1111/nmo.13142.
220. Okazaki M., Ferrandon S., Vilardaga J.P., Bouxsein M.L., Potts J.T. Jr., Gardella T.J. Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation. Proc Natl Acad Sci U S A. 2008; 105 (43): 16525-16530. doi: 10.1073/pnas.0808750105.
221. On J.S., Chow B.K., Lee L.T. Evolution of parathyroid hormone receptor family and their ligands in vertebrate. Front Endocrinol (Lausanne). 2015; 6: 28. doi: 10.3389/fendo.2015.00028.
222. Ono N., Nakashima K., Schipani E. Hayata T., Ezura Y., Soma K., Kronenberg H.M., Noda M. Constitutively active PTH/PTHrP receptor specifically expressed in osteoblasts enhances bone formation induced by bone marrow ablation. J. Cell Physiol. 2012; 227: 408-415.
223. Orloff J.J., Ganz M.B., Nathanson M.H., Moyer M.S., Kats Y., Mitnick M., Behal A., Gasalla-Herraiz J., Isales C.M. A midregion parathyroid hormonerelated peptide mobilizes cytosolic calcium and stimulates formation of inositoltrisphosphate in a squamous carcinoma cell line. Endocrinology. 1996; 137 (12): 5376-5385.
224. Orloff J.J., Ganz M.B., Ribaudo A.E. et al. Analysis of PTHRP binding and signal transduction mechanisms in benign and malignant squamous cells. Am J Physiol 1992; 262: E599-E607.
225. Orloff J.J., Kats Y., Urena P., Schipani E., Vasavada R.C., Philbrick W.M., Behal A., Abou-Samura A.-B., Segre G.V., Juppner H. Further evidence for a novel receptor for aminoterminal parathyroid hormone-related protein on keratinocytes and squamous carcinoma cell lines. Endocrinology. 1995; 136: 3016–3023.
226. Orloff J.J., Reddy D., Papp A.E. Yang K.H., Soifer N.E., Stewart A.F. Parathyroid hormone-related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev. 1994; 15: 40–60.
227. Palkovits M., Dobolyi A., Helfferich F., Usdin T.B. Localization and chemical characterization of the audiogenic stress pathway. Ann N Y Acad Sci. 2004; 1018: 16–24.
228. Pansuriya T.C., Kroon H.M., Bovee J.V. Enchondromatosis: insights on the different subtypes. Int J Clin Exp Pathol. 2010; 3 (6): 557-69.
229. Pansuriya T.C., Oosting J., Verdegaal S.H., Flanagan A.M., Sciot R., Kindblom L.G., Hogendoorn P.C., Szuhai K., Bovee J.V. Maffucci syndrome: a genome-wide analysis using high resolution single nucleotide polymorphism and expression arrays on four cases. Genes Chromosomes Cancer. 2011; 50 (9): 673-9. doi: 10.1002/gcc.2088.
230. Papasani M.R., Gensure R.C., Yan Y.L., Gunes Y., Postlethwait J.H., Ponugoti B., John M.R., Juppner H., Rubin D.A. Identification and characterization of the zebrafish and fugu genes encoding tuberoinfundibular peptide 39. Endocrinology. 2004; 145: 5294–5304.
231. Paspaliaris V., Petersen D.N., Thiede M.A. Steroid regulation of parathyroid hormone-related protein expression and action in the rat uterus. J Steroid Biochem Mol Biol. 1995; 53 (1-6): 259-265.
232. Pellegrini M., Royo M., Rosenblatt M., Chorev M., Mierke D.F. Addressing the tertiary structure of human parathyroid hormone-(1–34) J Biol Chem. 1998; 273: 10420–10427.
233. Philbrick W.M., Wysolmersli J.J., Galbraith S., Holt E., Orloff J.J., Yang K.H., Vasavada R.C., Weir E.C., Broadus A.E. and Stewart A.F. Defining the roles of the parathyroid hormone-related protein in normal physiology. Physiological Reviews. 1996; 76: 127–173.
234. Pilz P., Meyer-Marcotty P., Eigenthaler M., Roth H., Weber B.H., Stellzig-Eisenhauer A. Differential diagnosis of primary failure of eruption (PFE) with and without evidence of pathogenic mutations in the PTHR1 gene. J Orofac Orthop. 2014; 75 (3): 226-239.
235. Pinheiro P.L., Cardoso J.C.R., Power D.M., Canario A.V. Functional characterization and evolution of PTH/PTHrP receptors: insights from the chicken. BMC Evol Biol. 2012; 12: p. 110. doi: 10.1186/1471–2148-12–110.
236. Pinheiro P.L.C., Cardoso J.C.R., Gomes A.S., Fuentes J., Power D.M., Canario A.V. Gene structure, transcripts and calciotropic effects of the PTH family of peptides in Xenopus and chicken. BMC Evol Biol. 2010; 10: 373–379. doi: 10.1186/1471–2148-10-373.
237. Pioszak A.A., Parker N.R., Gardella T.J., Xu H.E. Structural basis for parathyroid hormone-related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides. J. Biol. Chem. 2009; 284: 28382-28391.
238. Pioszak A.A., Xu H.E. Molecular recognition of parathyroid hormone by its G protein-coupled receptor. Proc Natl Acad Sci USA.2008; 105: 5034–5039.
239. Piserchio A., Usdin T., Mierke D.F. Structure of tuberoinfundibular peptide of 39 residues. J Biol Chem. 2000; 275 (35): 27284-27290.
240. Pizurki L., Rizzoli R., Bonjour J.P. Inhibition by (D-Trp12, Tyr34)b PTH(7- 34) amide of PTH and PTHrP effects on Pi transport in renal cells. Am J Physiol. 1990; 259 (2 Pt 2): F389–392.
241. Pizzi H., Gladu J., Carpio L., Miao D., Goltzman D., Rabbani S.A. Androgen regulation of parathyroid hormone-related peptide production in human prostate cancer cells. Endocrinology. 2003; 144 (3): 858–867.
242. Plotkin H., Gundberg C., Mitnick M., Stewart A.F. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1–36) in humans: potential as an anabolic therapy for osteoporosis. J Clin Endocrinol Metab. 1998; 83 (8): 2786-2791.
243. Power D.M., Flanagan J.A., Fuentes J., Bendell L., Cana_rio A.V.M., Flik G., Ingleton PM. Parathyroid-hormone-related protein (PTHrP) and PTHrP receptor in developing sea bream (Abstract). J Endocrinol 1999; 163: P12.
244. Ray F.R., Barden J.A., Kemp B.E. NMR solution structure of the [Ala26] parathyroid-hormone-related protein(1–34) expressed in humoral hypercalcemia of malignancy. Eur J Biochem. 1993; 211 (1–2): p. 205-21.
245. Reiter E., Ahn S., Shukla A.K., and Lefkowitz R.J. Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol. 2012; 52: 179–197.
246. Rey A., Manen D., Rizzoli R., Caverzasio J., and Ferrari S.L. Proline-rich motifs in the parathyroid hormone (PTH)/PTH-related protein receptor C terminus mediate scaffolding of c-Src with beta-arrestin2 for ERK1/2 activation. J Biol Chem. 2006; 281: 38181–38188.
247. Richard V.A., Luchin R.M., Brena C. P., Rosol T.J. Quantitative evaluation of alternative promoter usage and 3′ splice variants for parathyroid hormone-related protein by real-time reverse transcription-PCR. Clin Chem. 2003; 49: 1398–1402.
248. Risom L., Christoffersen L., Daugaard-Jensen J., Hove H.D., Andersen H.S., Andresen B.S., Kreiborg S., Duno M. Identification of six novel PTH1R mutations in families with a history of primary failure of tooth eruption. PLoS ONE. 2013; 8: e74601.
249. Rodbell M. The complex regulation of receptor-coupled G-proteins. Adv Enzyme Regul. 1997; 37: 427–435.
250. Roques B.P., Noble F., Dauge V., Fournie-Zaluski M.C., Beaumont A. Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev. 1993; 45: 87–146.
251. Ross G., Engel P., Abdallah Y., Kummer W., Schluter K.D. Tuberoinfundibular peptide of 39 residues: a new mediator of cardiac function via nitric oxide production in the rat heart. Endocrinology. 2005; 146: 2221–2228.
252. Ross G., Heinemann M.P., Schluter K.D. Vasodilatory effect of tuberoinfundibular peptide (TIP39): requirement of receptor desensitization and its beneficial effect in the post-ischemic heart. Peptides. 2007; 28: 878–886.
253. Rotllant J., Guerreiro P.M., Anjos L., Redruello B., Canario A.V.M., Power D.M. Stimulation of cortisol release by the N terminus of teleost parathyroid hormone-related protein in interrenal cells in vitro. Endocrinology. 2005b; 146 (1): 71-76.
254. Rotllant J., Guerreiro P.M., Redruello B., Fernandes H., Apolonia L., Anjos L., Canario A.V., Power D.M. Ligand binding and signalling pathways of PTH receptors in sea bream (Sparus auratus) enterocytes. Cell Tissue Res. 2006; 323: 333–341.
255. Rotllant J., Redruello B., Guerreiro P.M., Fernandes H., Canario A.V., Power D.M. Calcium mobilization from fish scales is mediated by parathyroid hormone related protein via the parathyroid hormone type 1 receptor. RegulPept. 2005a; 132 (1–3): 33-40.
256. Rouffet J., Barlet J.P. Parathyroid hormone-related peptide (PTHrP) and bone metabolism. Arch Physiol Biochem. 1995; 103: 3–13.
257. Rozeman L.B., Sangiorgi L., Bruijn I.H., Mainil-Varlet P., Bertoni F., Cleton-Jansen A.M., Hogendoorn P.C., Bovee J.V. Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C. Hum Mutat. 2004; 24: 466-473. 10.1002/humu.20095.
258. Rubin D.A., Hellman P., Zon L.I., Lobb C.J., Bergwitz C., Juppner H.G. protein-coupled receptor from zebrafish is activated by human parathyroid hormone and not by human or teleost parathyroid hormone-related peptide. Implications for the evolutionary conservation of calcium-regulating peptide hormones. J Biol Chem. 1999; 274: 23035–23042. DOI: 10.1074/jbc.274.33.23035.
259. Rubin D.A., Juppner H. Zebrafish express the common parathyroid hormone/parathyroid hormone-related peptide receptor (PTH1R) and a novel receptor (PTH3R) that is preferentially activated by mammalian and fugufish parathyroid hormone-related peptide. J Biol Chem. 1999; 274 (40): 28185-28190.
260. Ruchon A.F., Marcinkiewicz M., Ellefsen K., Basak A., Aubin J., Crine P., Boileau G. Cellular localization of neprilysin in mouse bone tissue and putative role in hydrolysis of osteogenic peptides. J. Bone Miner. Res. 2000; 15: 1266–1274. doi: 10.1359/jbmr.2000.15.7.1266.
261. Saito H., Noda H., Gatault P., Bockenhauer D., Loke K.Y., Hiort O., Silve C., Sharwood E., Martin R.M1., Dillon M.J., Gillis D., Harris M., Rao S.D., Pauli R.M., Gardella T.J., Juppner H. Progression of Mineral Ion Abnormalities in Patients With Jansen Metaphyseal Chondrodysplasia. J Clin Endocrinol Metab. 2018; 103 (7): 2660-2669. doi: 10.1210/jc.2018-00332.
262. Sam R.J., Hoare S.R., Rubin D.A. Harald Juppner Ted B. Usdin.-Evaluating the Ligand Specificity of Zebrafish Parathyroid Hormone (PTH) Receptors: Comparison of PTH, PTH-Related Protein, and Tuberoinfundibular Peptide of 39 Residues. Endocrinology. 2000; 141 (9): 3080–3086.
263. Sanders J.L., Chattopadhyay N., Kifor O., Yamaguchi T., Brown E.M. Ca2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab. 2001; 281: E1267–E1274.
264. Schipani E., Jensen G.S., Pincus J., Nissenson R.A., Gardella T.J., and Juppner H. Constitutive activation of the cyclic adenosine 3′,5′-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen’s metaphyseal chondrodysplasia. Mol Endocrinol. 1997; 11: 851–858.
265. Schipani E., Langman C., Hunzelman J., Le Merrer M., Loke K.Y., Dillon M.J., Silve C., and Juppner H. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen’s metaphyseal chondrodysplasia. J Clin Endocrinol Metab. 1999; 84: 3052–3057.
266. Schipani E., Langman C.B., Parfitt A.M., Jensen G.S., Kikuchi S., Kooh S.W., Cole W.G., Juppner H. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal chondrodysplasia. N Engl J Med. 1996; 335 (10): 708–714.
267. Schipani E., Kruse K., Juppner H. A constitutively active mutant PTH/PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science. 1995; 268 (5207): 98–100.
268. Schluter K.D. PTH and PTHrP: similar structures but different functions. Physiology.1999; 14 (6): 243-249.
269. Schneider H., Feyen J.H., Seuwen K., Movva N.R. Cloning and functional expression of a human parathyroid hormone receptor. Eur J Pharmacol. 1993; 246 (2): 149–155. DOI: 10.1016/0922–4106 (93) 90092-n.
270. Schwindinger W.F., Fredericks J., Watkins L., Robinson H., Bathon J.M., Pines M., Suva L.J., Levine M.A. Coupling of the PTH/PTHrP receptor to multiple G-proteins. Direct demonstration of receptor activation of Gs, Gq/11, and Gi(1) by [alpha-32P]GTP-gamma-azidoanilide photoaffinity labeling. Endocrine. 1998; 8: 201–209.
271. Sebag M., Henderson J.E., Goltzman D., Kremer R. Regulation of parathyroid hormonerelated peptide production in normal human mammary epithelial cells in vitro. Am J Physiol 1994; 267: 723–730. DOI: 10.1152/ajpcell.1994.267.3. C. 723.
272. Segre G.V., Abou-Samra A.B., Juppner H., Schipani E., Force T., Urena P., Freeman M., Kong X.F., Kolakowski L.F., Jr, Hock J. et al. Characterization of cloned PTH/PTHrP receptors. J Endocrinol Invest. 1992; 15: 11–17.
273 Sellers R.S., Luchin A.I., Richard V., Brena R.M., Lima D., Rosol T.J. Alternative splicing of parathyroid hormone-related protein mRNA: expression and stability. J MolEndocrinol. 2004; 33 (1): 227-241.
274. Shigeta R., Cline M., Liu G. Siani-Rose M.A. GPCR-GRAPA-LIB-a refined library of hidden Markov Models for annotating GPCRs. Bioinformatics. 2003; 19 (5): 667-668. doi.org/10.1093/bioinformatics/btg061.
275. Shimizu M., Ichikawa F., Noda H., Okazaki M., Nakagawa C., Tamura T., Gardella T.J., Potts J.T., Ogata E., Kuromaru O. et al. A new long-acting PTH/PTHrP hybrid analog that Bbinds to a distinct PTHRconformation has superior efficacy in a rat model of hypoparathyroidism (Abstract). J Bone Miner Res. 2008; 23 (S1):S128.
276. Shimizu M., Potts J.T., Gardella T.J. Minimization of parathyroid hormone. Novel amino-terminal parathyroid hormone fragments with enhanced potency in activating the type-1 parathyroid hormone receptor. J Biol Chem. 2000; 275 (29): 21836-21843. DOI: 10.1074/jbc.M909861199.
277. Shimizu N., Guo J., Gardella T.J. Parathyroid hormone (PTH)-(1–14) and -(1–11) analogs conformationally constrained by alpha-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH-1 receptor. J Biol Chem. 2001; 276: 49003–49012.
278. Shoemaker J.M., Riley L.G., Hirano T., Grau E.G., Rubin D.A. Differential expression of tuberoinfundibular peptide 38 and glucose-6-phosphatase in tilapia. Gen Comp Endocrinol. 2005; 146 (2): 186-94. DOI: 10.1016/j.ygcen.2005.10.009.
279. Silve C., Juppner H. Genetic disorders caused by mutations in the PTH/PTHrP receptor and down-stream effector molecules. Genetics of Bone Biology and Skeletal Disease. 2018; (1): 655-674. doi: 10.1016/B978-0-12-804182-6.00036-8.
280. Smogorzewski M., Marcinkowski W., Zhang G. Parathyroidectomy does not affect mRNA of PTH-PTHrP receptor in kidney, liver, and heart // Amer. J. Nephrol. 1997; 17 (2): 187–192.
281. Sneddon W.B., Friedman P.A. Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and
parathyroid hormone type 1 receptor internalization. Endocrinology. 2007; 148: 4073–4079. doi: 10.1210/en.2007-0343.
282. Sneddon W.B., Syme C.A., Bisello A., Magyar C.E., Rochdi M.D., Parent J.L., Weinman E.J., Abou-Samra A.B., Friedman P.A. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J Biol Chem. 2003; 278: 43787–43796.
283. Soifer N.E., Dee K.E., Insogna K.L., Burtis W.J., Matovcik L.M., Wu T.L., Milstone L.M., Broadus A.E., Philbrick W.M., Stewart A.F. Parathyroid hormone-related protein. Evidence for secretion of a novel mid-region fragment by three different cell types. J. Biol. Chem. 1992; 267: 18236–18243.
284. Strewler G.J. The physiology of parathyroid hormone-related protein. New Eng J Med. 2000; 342: 177–185.
285. Strewler G.J., Stem P.H., Jacobs J.W., Eveloff J., Klein R.F., Leung S.C., Rosenblatt M., Nissenson R.A. Parathyroid hormonelike protein from human renal carcinoma cells structural and functional homology with parathyroid hormone. J Clin Invest. 1987; 80: 1803–1807. DOI: 10.1172/JCI113275.
286. Sugimura Y., Murase T., Ishizaki S., Tachikawa K., Arima H., Miura Y., Usdin T.B., Oiso Y. Centrally administered tuberoinfundibular peptide of 39 residues inhibits arginine vasopressin release in conscious rats. Endocrinology. 2003; 144: 2791–2796.
287. Sutkeviciute I., Clark L.J., White A.D., Gardella T.J., Vilardaga J-P.PTH/PTHrP Receptor Signaling, Allostery, and Structures. Trends in Endocrinology & Metabolism. 2019; 30 (11): 860-874.
288. Suva L.J., Mather K.A., Gillespie M.T., Webb G.C., Ng K.W., Winslow G.A., Wood W.I., Martin T.J., Hudson P.J. Structure of the 5′ flanking region of the gene encoding human parathyroid-hormone-related protein (PTHrP). Gene. 1989; 77: 95–105.
289. Suzuki N., Danks J.A., Maruyama Y., Ikegame M., Sasayama Y., Hattori A., Nakamura M., Tabata M.J., Yamamoto T., Furuya R., et al. Parathyroid hormone 1 (1–34) acts on the scales and involves calcium metabolism in goldfish. Bone. 2011; 48: 1186–1193.
290. Syme C.A., Friedman P.A., Bisello A. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of camp signaling. J. Biol. Chem. 2005; 280: 11281–11288. doi: 10.1074/jbc.M413393200.
291. Tanaka H., Smogorzewski M., Koss M., Massry S.G. Pathways involved in PTH-induced rise in cytosolic Ca2+ concentration of rat renal proximal tubule. Am J Physiol. 1995; 268: F330–337.
292. Tawfeek H.A. and Abou-Samra A.B. Important role for the V-type H(+)-ATPase and the Golgi apparatus in the recycling of PTH/PTHrP receptor. Am J Physiol Endocrinol Metab. 2004; 286: E704–E710.
293. Tawfeek H.A., Qian F., and Abou-Samra A.B. Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling. Mol Endocrinol. 2002; 16: 1–13.
294. Tehan B.G., Bortolato A., Blaney F.E., Weir M.P., and Mason J.S. Unifying family A GPCR theories of activation. Pharmacol Ther. 2014; 143: 51–60.
295. Tenne M., McGuigan F., Jansson L. et al. Genetic variation in the PTH pathway and bone phenotypes in elderly women: evaluation of PTH, PTHLH, PTHR1 and PTHR2 genes. Bone. 2008; 42 (4): 719-727.
296. Thiede M.A., Rodan G.A. Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Science. 1988; 242: 278-280.
297. Thota C.S., Reed L.C., Yallampalli C. Effects of parathyroid hormone like hormone (PTHLH) antagonist, PTHLH7–34, on fetoplacental development and growth during midgestation in rats. Biol. Reprod. 2005; 73: 1191–1198.
298. Toribio R.E., Brown H.A., Novince C.M., Marlow B., Hernon K., Lanigan L.G., Hildreth B.E. 3rd., Werbeck J.L., Shu S.T., Lorch G., Carlton M., Foley J., Boyaka P., McCauley L.K., Rosol T.J. The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice. FASEB J.2010; 24: 1947–1957.
299. Trivett M.K., Potter I.C., Power G., Zhou H., Macmillan D.L., Martin T.J. et al. Parathyroid hormone-related protein production in the lamprey Geotria australis: developmental and evolutionary perspectives. Dev Genes EVol. 2005; 215: 553–63.
300. Truelove A., Mulay A., Prapa M., Casey R.T., Adler A.I., Offiah A.C., Poole K.E.S., Trotman J., Al Hasso N., Park S.M. Identification of novel pathogenic variants and features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly classified inactivating PTH/PTHrP signaling disorders. Am J Med Genet Part A. 2019; 179A: 1330– 1337. doi.org/10.1002/ajmg.a.61163.
301. Tucci J., Russel A., Senior P.V., Fernley R., Ferraro T., Beck F. The expression of parathyroid hormone and parathyroid hormone-related protein in developing rat parathyroid glands. J Mol Endocrinol. 1996; 17: 149–57.
302. Turk B. Targeting proteases: Successes, failures and future prospects. Nat. Rev. Drug Discov. 2006; 5: 785–799. doi: 10.1038/nrd2092.
303. Turner A.J., Tanzawa K. Mammalian membrane metallopeptidases: Nep, ece, kell, and pex. FASEB J. 1997; 11: 355–364. doi: 10.1096/fasebj.11.5.9141502.
304. Urena P., Kong X.F., Abou-Samra A.B., Juppner H., Kronenberg H.M., Potts J.T. Jr., Segre G.V. Parathyroid hormone (PTH)/PTHrelated peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology. 1993; 133: 617–623. DOI: 10.1210/endo.133.2.8393771.
305. Usdin T.B. Evidence for a parathyroid hormone-2 receptor selective ligand in the hypothalamus. Endocrinology. 1997; 138: 831–834.
306. Usdin T.B. The PTH2 receptor and TIP39: a new peptide-receptor system. Trends Pharmacol Sci. 2000; 21: 128–130.
307. Usdin T.B., Bonner T.I., Harta G., Mezey E. Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat. Endocrinology. 1996; 137: 4285–4297.
308. Usdin T.B., Gruber C., Bonner T.I. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem. 1995; 270 (26): 15455-15458.
309. Usdin T.B., Hilton J., Vertesi T., Harta G., Segre G., Mezey E. Distribution of the parathyroid hormone 2 receptor in rat: immunolocalization reveals expression by several endocrine cells. Endocrinology. 1999b; 140: 3363–3371. doi: 10.1210/en.140.7.3363.
310. Usdin T.B., Hoare S.R., Wang T., Mezey E., Kowalak J.A. TIP39: a new neuropeptide and PTH2-receptor agonist from hypothalamus. Nat Neurosci.1999a; 2 (11): p. 941-943. DOI: 10.1038/14724.
311. Usdin T.B., Wang T., Hoare S.R., Mezey E., Palkovits M. New members of the parathyroid hormone/parathyroid hormone receptor family: the parathyroid hormone 2 receptor and tuberoinfundibular peptide of 39 residues. Front Neuroendocrinol. 2000; 21: 349–383.
312. Usdin T.B., Paciga M., Riordan T., Kuo J., Parmelee A., Petukova G., Camerini-Otero R.D., Mezey E. Tuberoinfundibular Peptide of 39 residues is required for germ cell development. Endocrinology. 2008; 149: 4292–4300.
313. Valin A., Guillen C., Esbrit P. C-terminal parathyroid hormone-related protein (PTHrP) (107–139) stimulates intracellular Ca(2+) through a receptor different from the type 1 PTH/PTHrP receptor in osteoblastic osteosarcoma UMR 106 cells. Endocrinology. 2001; 142: 2752-2759.
314. Vasavada R.C. Wysolmerski J.J. Broadus A.E. and Philbrick W.M. Identification and characterization of a GC-rich promoter of the human parathyroid hormonerelated peptide gene. Mol Endocrinol. 1993; 7: 273–282.
315. Vilardaga J., Frank M., Krasel C., Dees C., Nissenson R., and Lohse M. Differential conformational requirements for activation of G proteins and regulatory proteins, arrestin and GRK in the G protein coupled receptor for parathyroid hormone (PTH)/PTH related protein. J Biol Chem. 2001; 276 (36): 33435-33443. DOI: 10.1074/jbc.M011495200.
316. Vilardaga J.P., Gardella T.J., Wehbi V.L., Feinstein T.N. Non-canonical signaling of the PTH receptor. Trends Pharmacol Sci. 2012; 33: 423–431.
317. Vilardaga J.P., Jean-Alphonse F.G., Gardella T.J. Endosomal generation of cAMP in GPCR signaling. Nat Chem Biol. 2014; 10: 700–706.
318. Vilardaga J.P., Krasel C., Chauvin S., Bambino T., Lohse M.J., and Nissenson R.A. Internalization determinants of the parathyroid hormone receptor differentially regulate beta-arrestin/receptor association. J Biol Chem. 2002; 277: 8121–8129.
319. Wang B., Bisello A., Yang Y., Romero G.G., and Friedman A. NHERF1 regulates parathyroid hormone receptor membrane retention without affecting recycling. J Biol Chem. 2007; 282: 36214–36222.
320. Wang B., Yang Y., Abou-Samra A.B., Friedman P.A. NHERF1 regulates parathyroid hormone receptor desensitization: interference with beta-arrestin binding. Mol Pharmacol. 2009; 75 (5): 1189-97. doi: 10.1124/mol.108.054486.
321. Wang J., Coolen L.M., Brown J.L., Usdin T.B. Neurons containing tuberoinfundibular peptide of 39 residues are activated following male sexual behavior. Neuropeptides. 2006a; 40: 403–408.
322. Wang N., Li P., Liu W., Wang N., Lu Z., Feng J., Zeng X., Yang J., Wang Y., Zhao W. Mir-141–3p suppresses proliferation and promotes apoptosis by targeting gli2 in osteosarcoma cells. Oncol Rep. 2018; 39: 747–754. doi: 10.3892/or.2017.6150.
323. Wang T., Palkovits M., Rusnak M., Mezey E., Usdin T.B. Distribution of parathyroid hormone-2 receptor-like immunoreactivity and messenger RNA in the rat nervous system. Neuroscience. 2000; 100: 629–649.
324. Ward H.L., Small C.J., Murphy K.G., Kennedy A.R., Ghatei M.A., Bloom S.R. The actions of tuberoinfundibular peptide on the hypothalamo-pituitary axes. Endocrinology. 2001; 142: 3451–3456.
325. Watson P.H., Hodsman A.B., Fraher L.J., Chung U.I., Kisiel M., Natale B.V., Hodsman A.B. Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues. J Bone Miner Res. 2000; 15 (6): 1033-1044. DOI: 10.1359/jbmr.2000.15.6.1033.
326. Weaver R.E., Mobarec J.C., Wigglesworth M.J., Reynolds C.A., Donnelly D. High affinity binding of the peptide agonist TIP-39 to the Parathyroid hormone 2 PTH2 receptor requires the hydroxyl group of Tyr-318
on transmembrane helix 5. Biochemical Pharmacology. 2017; 127: 71–81. doi: 101016/jbcp201612013.
327. Weidler M., Marx U.C., Seidel G., Schafer W., Hoffmann E., Eβwein A., Rosch P. The structure of human parathyroid hormone-related protein(1–34) in near-physiological solution. FEBS Letters. 1999; 444 (2–3): 239-244.
328. Weir E.C., Brines M.L., Ikeda K., Burtis W.J., Broadus A.E., Robbins R.J. Parathyroid hormone-related peptide gene is expressed in the mammalian central nervous system. Proc Natl Acad Sci U S A. 1990; 87 (1): 108-12.
329. White A.D., Fang F., Jean-Alphonse F.G., Clark L.J., An H.J., Liu H., Zhao Y., Reynolds S.L., Lee S., Xiao K., Sutkeviciute I., Vilardaga J.P. Ca2+ allostery in PTH-receptor signaling. Proc Natl Acad Sci U S A. 2019; 116 (8): 3294-3299. doi: 10.1073/pnas.1814670116.
330. Whitfield J.F. Parathyroid hormone-related protein (PTHrP): an ancient string of cytokines with many known and still unknown functions. In Novel Aspects of PTHrP Physiopathology; Luparello C., Ed; Nova Science Publishers: New York, NY, USA, 2007; pp. 1–25.
331. Whitfield J.F., Bringhurst F.R. Lactam formation increases receptor binding, adenylyl cyclase stimulation and bone growth stimulation by human parathyroid hormone (hPTH) (1–28)NH2. J Bone Miner Res. 2000; 15 (5): 964-970.
332. Whitfield J.F., Morley P. Small bone-building fragments of parathyroid hormone: new therapeutic agents for osteoporosis. Trends Pharmacol Sci. 1995; 16 (11): 382-386.
333. Wittelsberger A., Corich M., Thomas B.E., Lee B.K., Barazza A., Czodrowski P., Mierke D.F., Chorev M., and Rosenblatt M. The mid-region of parathyroid hormone (1–34) serves as a functional docking domain in receptor activation. Biochemistry. 2006; 45: 2027–2034.
334. Wysolmerski J.J. Parathyroid hormone-related protein: An update. Clin. Endocrinol. Metab. 2012,; 97: 2947–2956.
335. Yamaguchi T., Hosomichi K., Narita A., Shirota T., Tomoyasu Y., Maki K., Inoue I. Exome resequencing combined with linkage analysis identifies novel PTH1R variants in primary failure of tooth eruption in Japanese. J Bone Miner Res. 2011; 26: 1655–1661.
336. Yamamoto S., Morimoto I., Yanagihara N., Zeki K., Fujihira T., Izumi F., Yamashita H. eto S. Parathyroid hormone-related peptide-(1–34) [PTHrP-(1–34)] induces vasopressin release from the rat supraoptic nucleus in vitro through a novel receptor distinct from a type I or type II PTH/PTHrP receptor. Endocrinology. 1997; 138: 2066-2072.
337. Yang K.H., dePapp A.E., Soifer N.E., Dreyer B.E., Wu T.L., Porter S.E., Bellantoni M., Burtis W.J., Insogna K.L., Broadus A.E. Parathyroid hormone-related protein: evidence for isoform- and tissue-specific posttranslational processing. Biochemistry. 1994; 33 (23): 7460-9.
338. Yasuda T., Banville D., Hendy G.N., Goltzman D. Characterization of the human parathyroid hormone-likepeptide gene. Functional and evolutionary aspects. J BiolChem. 1989; 264 (13): 7720-5.
339. Zhang P., Jobert A.S., Couvineau A., Silve C. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab. 1998; 83: 3365–3368.
340. Zhao L.H., Ma S., Sutkeviciute I., Shen D.D., Zhou X.E., de Waal P.W., Li C.Y., Kang Y., Clark L.J., Jean-Alphonse F.G., White A.D., Yang D., Dai A., Cai X., Chen J., Li C., Jiang Y., Watanabe T., Gardella T.J., Melcher K., Wang M.W., Vilardaga J.P., Xu H.E., Zhang Y. Structure and dynamics of the active human parathyroid hormone receptor-1. Science. 2019; 364 (6436): 148-153. doi: 10.1126/science.aav7942.
341. Zheng H.L., Li H., Sun Y.S., Yang Z.Y., Yu Q. Parathyroid hormone-related peptide (PTHrP): prokaryotic expression, purification, and preparation of a polyclonal antibody. Genetics and Molecular Research. 2014, 13 (3): 6448–6454. DOI: 10.4238/2014. August.25.8.
342. Zheng M.H., Mc Caughan H.B., Papadimitriou J.M., Nicholson G.C., Wood D.J. Tartrate resistant acid phosphatase activity in rat cultured osteoclasts is inhibited by a carboxyl terminal peptide (osteostatin) from parathyroid hormone-related protein. J Cell Biochem. 1994; 54: 145–153. DOI: 10.1002/jcb.240540203.
343. Zhou X.E., He Y., de Waal P.W., Gao X., Kang Y., Van Eps N. et al. Structural identification of phosphorylation codes for arrestin recruitment by G protein-coupled receptors. Cell. 2017; 170 (3): 457-469.e13. doi: 10.1016/j.cell.2017.07.002.
344. Zhu X., Gilbert S., Birnbaumer M., Birnbaumer L. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Mol Pharmacol. 1994; 46: 460–469.
345. Zuscik M.J., O′Keefe R.J., Gunter T.E., Puzas J.E., Schwarz E.M., Rosier R.N. Parathyroid hormone-related peptide regulation of chick tibial growth plate chondrocyte maturation requires protein kinase A. J Orthop Res. 2002; 20 (5): 1079–1090. DOI: 10.1016/S0736-0266 (02) 00027-X.